Close Menu

Integrated Diagnostics

Company researchers showed that the agents could selectively target single point mutations not associated with protein-binding pockets.

Many of the meeting's proteomics presentations concerned not so much mass spec analysis itself as the refinement of processes and workflows leading up to it.

The MRM-MS-based method combines use of conventional stable isotope-labeled peptide standards with a series of endogenous protein standards.

The company hopes to launch the test sometime this year after completing CLIA certification of its clinical laboratory and securing reimbursement.

The agreement gives Caprion, which did significant development work on the test, exclusive rights to market and commercialize Xpresys Lung inCanada.

The 141-sample study found the test could identify benign lesions in lung cancer patients with a negative predictive value of between 84 percent and 98 percent.

From research collaborations to corporate acquisitions, attention from the broader scientific community highlighted the field's capabilities and limitations.

The collaboration will explore use of the PCC agents, which are synthetic peptides with functions similar to traditional antibodies, for protein research.

NEW YORK (GenomeWeb) – With a series of recent payor decisions, Integrated Diagnostics now has more than 200 million covered lives for its Xpresys Lung cancer test.

NEW YORK (GenomeWeb) – Integrated Diagnostics said today that recent payor decisions have given it more than 200 million covered lives for its Xpresys Lung cancer test.

Pages

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.